From: Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy
Characteristics
Number of patients
34
Median age (range)
59 (29–79)
Sex
Male
25 (73.5%)
Female
9 (26.5%)
Clinical T stage
T1–2
1 (2.9%)
T3–4
33 (97.1%)
Clinical N stage
N−
3 (8.8%)
N+
31 (91.2%)
CEA (ng/mL)
< 5.0
17 (50%)
≥ 5.0